| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $238.7M | +32.4% |
| Cost of Revenue | $181.8M | +3.7% |
| Gross Profit | $56.9M | +1043.9% |
| R&D Expense | $16.4M | -3.4% |
| SG&A Expense | $56.8M | +47.4% |
| Operating Income | -$49.2M | +37.9% |
| Net Income | -$45.8M | +44.6% |
| EPS (Basic) | -$0.66 | +68.6% |
| EPS (Diluted) | -$0.66 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $139.7M | -50.3% |
| Accounts Receivable | $70.0M | +22.0% |
| Inventory | $39.2M | +73.9% |
| Current Assets | $266.3M | -28.0% |
| Total Assets | $703.0M | +9.3% |
| Current Liabilities | $78.1M | -1.1% |
| Total Liabilities | $215.0M | +9.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.6M | +54.9% |
| Capital Expenditures | $175.5M | -1.4% |
| Investing Cash Flow | -$175.5M | +1.4% |
| Financing Cash Flow | $75.5M | -84.2% |
| Free Cash Flow | -$218.1M | +19.9% |
| +68.6% |
| Stockholders' Equity |
| $488.1M |
| +9.1% |